All Comparisons/Manchester Imaging vs CellmatiQ

VNDRIQ — Vendor Comparison

Manchester Imaging vs CellmatiQ

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Manchester Imaging47
CellmatiQ35

Manchester Imaging

Dental Imaging AI

Verification pending

CellmatiQ

Dental Imaging AI

Verification pending

VNDRIQ Scores

47

Overall

Privacy Score36
Governance Score55
Healthcare Readiness42
AI Risk Score55

35

Overall

Privacy Score36
Governance Score37
Healthcare Readiness35
AI Risk Score30

Approval Tier

Conditional / Verify BAA
Restricted / Review Required

BAA Status

Not explicitly stated; the company is based in the UK and emphasizes GDPR compliance and ISO-13485 standards for medical devices.
No public Business Associate Agreement (BAA) was identified in the search results; the company primarily emphasizes EU CE certification and GDPR compliance.

PHI Exposure Risk

High
High

AI Training Risk

Medium
High

HIPAA Risk Level

High
High

Review Frequency

Quarterly

Quarterly

Recommended Use

AI-assisted detection of enamel-only proximal caries and osteoporosis risk assessment (OsteoDent) from dental X-rays.

Automated cephalometric landmark identification and diagnostic support for dental pathologies in clinical settings.

Restrictions

Primarily marketed in the UK and used in university dental schools; US clinical use requires verification of FDA 510(k) clearance which is not explicitly documented in current search results.

Primarily certified for the EU market (CE mark); FDA clearance for the US market is not confirmed in available documentation.

Executive Summary

Manchester Imaging

Dental Imaging AI

Manchester Imaging is classified as Conditional / Verify BAA with a BAA status of Not explicitly stated; the company is based in the UK and emphasizes GDPR compliance and ISO-13485 standards for medical devices.. PHI exposure is rated High and AI training risk is Medium. AI-assisted detection of enamel-only proximal caries and osteoporosis risk assessment (OsteoDent) from dental X-rays.

36

Privacy

55

Governance

42

Healthcare

55

AI Risk

CellmatiQ

Dental Imaging AI

CellmatiQ is classified as Restricted / Review Required with a BAA status of No public Business Associate Agreement (BAA) was identified in the search results; the company primarily emphasizes EU CE certification and GDPR compliance.. PHI exposure is rated High and AI training risk is High. Automated cephalometric landmark identification and diagnostic support for dental pathologies in clinical settings.

36

Privacy

37

Governance

35

Healthcare

30

AI Risk

Recommended For

Manchester Imaging

AI-assisted detection of enamel-only proximal caries and osteoporosis risk assessment (OsteoDent) from dental X-rays.

Organizations able to execute BAA prior to deployment

IT teams with capacity to verify data handling agreements

CellmatiQ

Automated cephalometric landmark identification and diagnostic support for dental pathologies in clinical settings.

Currently under review — not recommended for active PHI deployment

Governance Considerations

Manchester Imaging

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Primarily marketed in the UK and used in university dental schools; US clinical use requires verification of FDA 510(k) clearance which is not explicitly documented in current search results.

CellmatiQ

Verify model training opt-out clauses before deployment.

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Primarily certified for the EU market (CE mark); FDA clearance for the US market is not confirmed in available documentation.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.